Filing Details

Accession Number:
0001078782-20-000704
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-18 17:21:16
Reporting Period:
2020-09-15
Accepted Time:
2020-09-18 17:21:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1567531 Md Bradley Jason Terrell 13215 Bee Cave Parkway
Suite 125, Galleria Oaks B
Austin TX 78738
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-09-15 19,500 $3.23 34,949 No 4 S Direct
Common Stock Acquisiton 2020-09-18 25,000 $2.47 59,949 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Disposition 2020-09-18 25,000 $0.00 25,000 $2.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-09-18 2020-09-18 No 4 M Direct
Footnotes
  1. On September 18, 2020, the Reporting Person exercised a warrant to purchase 25,000 shares of Common Stock of the issuer for $2.47 per share. The warrant was set to expire pursuant to its terms on September 18, 2020.